A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis

Autor:	Radhakrishnan Pillai, Zoe Diana Draelos, Tina Lin, Stephen K. Tyring, Francisco A. Kerdel
Rok vydání:	2018
Předmět:	Adult Male medicine.medical_specialty Halobetasol Skin Cream Dermatology Administration Cutaneous Double blind Clinical study 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Double-Blind Method HALOBETASOL PROPIONATE 0.05% CREAM Psoriasis medicine Humans Aged 030203 arthritis & rheumatology Clobetasol Halobetasol Propionate Dose-Response Relationship Drug business.industry Middle Aged medicine.disease Clinical trial Treatment Outcome Lotion Female Dermatologic Agents business medicine.drug
Zdroj:	Journal of Dermatological Treatment. 30:333-339
ISSN:	1471-1753 0954-6634
DOI:	10.1080/09546634.2018.1523362
Popis:	Background: Halobetasol propionate (HP) 0.05% is a highly effective short-term treatment for plaque psoriasis.Objective: Compare efficacy and safety of once-daily HP 0.01% lotion and 0.05% cream (U...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead3b002cdc506ee9a3c52700c16241e https://doi.org/10.1080/09546634.2018.1523362 Zobrazit plný text záznamu